Cargando…
Intra-Amniotic Delivery of CRMP4 siRNA Improves Mesenchymal Stem Cell Therapy in a Rat Spina Bifida Model
Neural tube defects (NTDs) result in prenatal mortality and lifelong morbidity, and available treatments have limited efficacy. We previously suggested that prenatal bone marrow-derived mesenchymal stem cell (BMSC) transplantation could treat neuron deficiency in NTD rats; however, BMSC-based therap...
Autores principales: | Wei, Xiaowei, Cao, Songying, Ma, Wei, Zhang, Chaonan, Gu, Hui, Liu, Dan, Luo, Wenting, Bai, Yuzuo, Wang, Weilin, Yuan, Zhengwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177192/ https://www.ncbi.nlm.nih.gov/pubmed/32330869 http://dx.doi.org/10.1016/j.omtn.2020.03.007 |
Ejemplares similares
-
Intra‐amniotic mesenchymal stem cell therapy improves the amniotic fluid microenvironment in rat spina bifida aperta fetuses
por: Wei, Xiaowei, et al.
Publicado: (2022) -
Intra-amniotic transplantation of brain-derived neurotrophic factor-modified mesenchymal stem cells treatment for rat fetuses with spina bifida aperta
por: Ma, Wei, et al.
Publicado: (2022) -
Application potential of bone marrow mesenchymal stem cell (BMSCs) based tissue-engineering for spinal cord defect repair in rat fetuses with spina bifida aperta
por: Li, Xiaoshuai, et al.
Publicado: (2016) -
Spina Bifida
Publicado: (1891) -
Spina Bifida
Publicado: (1890)